Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release

Journal of Virology

Volumn 79, Issue 24, 2005, Pages 15074-15083

  Stanke, Nicole ^a   Stange, Annett ^a   Lüftenegger, Daniel ^a   Zentgraf, Hanswalter ^b   Lindemann, Dirk ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; FURIN LIKE PROTEINASE; GAG PROTEIN; LEADER PEPTIDE GLYCOPROTEIN GP 18; LEADER PEPTIDE GLYCOPROTEIN GP 28; LEADER PEPTIDE GLYCOPROTEIN GP 38; LYSINE; MEMBRANE PROTEIN; MUTANT PROTEIN; PROTEIN PRECURSOR; PROTEIN SUBUNIT; PROTEINASE; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOASSAY; CYTOPLASMIC DOMAIN; ELECTRON MICROSCOPY; GLYCOPROTEIN SYNTHESIS; HUMAN; HUMAN CELL; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN VARIANT; REGULATORY MECHANISM; SINGLE CYCLE INFECTIVITY ASSAY; SPUMA VIRUS; SUBVIRUS PARTICLE; UBIQUITINATION; VIRUS INFECTIVITY; VIRUS PARTICLE;

CELL LINE; PROTEIN SORTING SIGNALS; SPUMAVIRUS; UBIQUITIN; VIRAL ENVELOPE PROTEINS; VIRUS SHEDDING;

HUMAN SPUMARETROVIRUS; SPUMAVIRUS;

EID: 29744434741     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.24.15074-15083.2005     Document Type: Article

References (44)

1. Baunach, G., B. Maurer, H. Hahn, M. Kranz, and A. Rethwilm. 1993. Functional analysis of human foamy virus accessory reading frames. J. Virol. 67:5411-5418.
2. Bültmann, A., J. Eberle, and J. Haas. 2000. Ubiquitination of the human immunodeficiency virus type 1 Env glycoprotein, J. Virol. 74:5373-5376.
3. Cosson, P. 1996. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15:5783-5788.
4. Du Bridge, R. B., P. Tang, H. C. Hsia, P. M. Leong, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
5. Duda, A., A. Stange, D. Lüftenegger, N. Stanke, D. Westphal, T. Pietschmann, S. W. Eastman, M. L. Linial, A. Rethwilm, and D. Lindemann. 2004. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J. Virol. 78:13865-13870.
6. Eastman, S. W., and M. L. Linial. 2001. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J. Virol. 75:6857-6864.
7. Geiselhart, V., P. Bastone, T. Kempf, M. Schnolzer, and M. Löchelt. 2004. Furin-mediated cleavage of the feline foamy virus Env leader protein. J. Virol. 78:13573-13581.
8. Geiselhart, V., A. Schwantes, P. Bastone, M. Frech, and M. Löchelt. 2003. Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis. Virology 310:235-244.
9. Gottwein, E., and H. G. Kräusslich. 2005. Analysis of human immunodeficiency virus type 1 Gag ubiquitination. J. Virol. 79:9134-9144.
10. Heinkelein, M., C. Leurs, M. Rammling, K. Peters, H. Hanenberg, and A. Rethwilm. 2002. Pregenomic RNA is required for efficient incorporation of Pol polyprotein into foamy virus capsids. J. Virol. 76:10069-10073.
11. Kräusslich, H. G., M. Fàcke, A. M. Heuser, J. Konvalinka, and H. Zentgraf. 1995. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69:3407-3419.
12. Lindemann, D., M. Bock, M. Schweizer, and A. Rethwilm. 1997. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:4815-4820.
13. Lindemann, D., and P. A. Goepfert. 2003. The foamy virus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 277:111-129.
14. Lindemann, D., T. Pietschmann, M. Picard-Maureau, A. Berg, M. Heinkelein, J. Thurow, P. Knaus, H. Zentgraf, and A. Rethwilm. 2001. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J. Virol. 75:5762-5771.
15. Lindemann, D., and A. Rethwilm. 1998. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J. Virol. 72:4088-4094.
16. Linial, M. L., and S. W. Eastman. 2003. Particle assembly and genome packaging. Curr. Top. Microbiol. Immunol. 277:89-110.
17. Lüftenegger, D., M. Picard-Maureau, N. Stanke, A. Rethwilm, and D. Lindemann. 2005. Analysis and function of prototype foamy virus envelope N glycosylation. J. Virol. 79:7664-7672.
18. Mimnaugh, E. G., P. Bonvini, and L. Neckers. 1999. The measurement of ubiquitin and ubiquitinated proteins. Electrophoresis 20:418-428.
19. Moebes, A., J. Enssle, P. D. Bieniasz, M. Heinkelein, D. Lindemann, M. Bock, M. O. McClure, and A. Rethwilm. 1997. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71:7305-7311.
20. Murakami, T., and E. O. Freed. 2000. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74:3548-3554.
21. Ott, D. E., L. V. Coren, E. N. Chertova, T. D. Gagliardi, and U. Schubert. 2000. Ubiquitination of HIV-1 and MuLV Gag. Virology 278:111-121.
22. Gag protein of Moloney murine leukemia virus. J. Virol. 72:2962-2968.
23. Ott, D. E., L. V. Coren, R. C. Sowder, 2nd, J. Adams, K. Nagashima, and U. Schubert. 2002. Equine infectious anemia virus and the ubiquicin-proteasome system. J. Virol. 76:3038-3044.
24. Ott, D. E., L. V. Coren, R. C. Sowder, 2nd, J. Adams, and U. Schubert. 2003. Retroviruses have differing requirements for proteasome function in the budding process. J. Virol. 77:3384-3393.
25. Patton, G. S., S. A. Morris, W. Chung, P. D. Bieniasz, and M. O. McClure. 2005. Identification of domains in gag important for prototypic foamy virus egress. J. Virol. 79:6392-6399.
26. Pelchen-Matthews, A., G. Raposo, and M. Marsh. 2004. Endosomes, exosomes and Trojan viruses. Trends Microbiol. 12:310-316.
27. Pietschmann, T., M. Heinkelein, M. Heldmann, H. Zentgraf, A. Rethwilm, and D. Lindemann. 1999. Foamy virus capsids require the cognate envelope protein for particle export. J. Virol. 73:2613-2621.
28. Pietschmann, T., H. Zentgraf, A. Rethwilm, and D. Lindemann. 2000. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J. Virol. 74:4474-4482.
29. Putterman, D., R. B. Pepinsky, and V. M. Vogt. 1990. Ubiquitin in avian leukosis virus particles. Virology 176:633-637.
30. Rasheed, S., W. A. Nelson-Rees, E. M. Toth, P. Arnstein, and M. B. Gardner. 1974. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33:1027-1033.
31. Resh, M. D. 1999. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451:1-16.
32. Rethwilm, A. 2003. The replication strategy of foamy viruses. Curr. Top. Microbiol. Immunol. 277:1-26.
33. Schmidt, M., and A. Rethwilm. 1995. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 210:167-178.
34. Schubert, U., D. E. Ott, E. N. Chertova, R. Welker, U. Tessmer, M. F. Princiotta, J. R. Bennink, H. G. Kräusslich, and J. W. Yewdell. 2000. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. USA 97:13057-13062.
35. Sfakianos, J. N., and E. Hunter. 2003. M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome. Traffic 4:671-680.
36. Shaw, K. L., D. Lindemann, M. J. Mulligan, and P. A. Goepfert. 2003. Foamy virus envelope glycoprotein is sufficient for particle budding and release. J. Virol. 77:2338-2348.
37. Song, C., S. R. Dubay, and E. Hunter. 2003. A tyrosine motif in the cytoplasmic domain of Mason-Pfizer monkey virus is essential for the incorporation of glycoprotein into virions. J. Virol. 77:5192-5200.
38. Stange, A., I. Mannigel, K. Peters, M. Heinkelein, N. Stanke, M. Cartellieri, H. Göttlinger, A. Rethwilm, H. Zentgraf, and D. Lindemann. 2005. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J. Virol. 79:5466-5476.
39. Strack, B., A. Calistri, and H. G. Göttlinger. 2002. Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis. J. Virol. 76:5472-5479.
40. Swanstrom, R., and J. W. Wills. 1997. Synthesis, assembly, and processing of viral proteins, p. 263-334. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
41. Vogt, V. M. 2000. Ubiquitin in retrovirus assembly: actor or bystander? Proc. Natl. Acad. Sci. USA 97:12945-12947.
42. Wilk, T., F. de Haas, A. Wagner, T. Rutten, S. Fuller, R. M. Flügel, and M. Löchelt. 2000. The intact retroviral Env glycoprotein of human foamy virus is a trimer. J. Virol. 74:2885-2887.
43. Wilk, T., V. Geiselhart, M. Frech, S. D. Fuller, R. M. Flügel, and M. Löchelt. 2001. Specific interaction of a novel foamy virus env leader protein with the N-terminal gag domain. J. Virol. 75:7995-8007.
44. Gag in immature human immunodeficiency virus type 1 particles. J. Virol. 74:9381-9387.